©The Author(s) 2022.
World J Hepatol. Apr 27, 2022; 14(4): 696-707
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.696
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.696
Table 1 Major advantages and limitations of noninvasive periportal fibrosis markers in Schistosomiasis mansoni infected patients
| Feature | Liver biopsy | Serum markers | Imaging techniques | |||
| Wedged | Percutaneous | US | pSWE | TE | ||
| Invasiveness | High | High | Minimal | None | None | None |
| Post-procedural risk | Possible | Possible | Minimal | None | None | None |
| Accuracy for PPF prediction | High | Low | Medium to high | High | Good | Good |
| Sensitivity | High | Low | Medium | High | Medium | Medium |
| Interpretation | Subjective | Subjective | Objective | Subjective | Objective | Objective |
| Observer variability | High | High | Low | High | Not yet evaluated | Not yet evaluated |
| Costs | High | Medium | Depends | Medium | Medium | Medium |
| Limitations by anthropometric features | High | High | None | Medium | Medium | Medium |
| Suitability for monitoring PPF | Low | Low | High | High | High | High |
- Citation: Santos JC, Pereira CLD, Domingues ALC, Lopes EP. Noninvasive diagnosis of periportal fibrosis in schistosomiasis mansoni: A comprehensive review. World J Hepatol 2022; 14(4): 696-707
- URL: https://www.wjgnet.com/1948-5182/full/v14/i4/696.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i4.696